By Drug Target Review2025-01-17T08:00:02
Researchers have identified early molecular changes in Rett syndrome that could lead to improved treatments for the condition.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2024-01-19T07:40:55
Sponsored by Euretos
2025-05-14T14:30:00
Sponsored by Abzena
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-05-10T11:18:16
Sponsored by Revvity
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud